Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03203954 · ClinicalTrials.gov registry record · NA
Testing the Neuroscience of Guided Learning in Depression
A NA study, sponsored by Virginia Polytechnic Institute and State University.
- Completed
- Registry status
- NA
- Development phase
- 216
- Enrollment target
NCT03203954: Completed NA study, sponsored by Virginia Polytechnic Institute and State University.
NCT03203954 is a NA study that has completed, run by Virginia Polytechnic Institute and State University. The registered enrollment target is 216 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (85% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03203954, a NA study, has completed, sponsored by Virginia Polytechnic Institute and State University.
- COMPLETED
- Registry status
- NA
- Development phase
- 216 participants
- Enrollment target
Study Summary
Major depression is a prevalent and impairing illness. To better understand the basic science and treatment of depression, the investigators study the behavioral and brain processes associated with learning in depression and how potential disruptions in learning may be repaired. Understanding different methods that change learning may lead to novel treatments that contribute to recovery in people with depression.
Primary Outcome
behavioral measures of learning task performance including accuracy, learning rate
Interventions
- BEHAVIORAL Standard Learning
- BEHAVIORAL Guided Learning: Instructed statistics
- BEHAVIORAL Guided Learning: Changing statistics
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 216 participants |
| Start Date | 2016-05-01 |
| Est. Completion | 2021-12 |
| Phase | NA |
What the finished NCT03203954 record still lists
NCT03203954 is an interventional study that assigns participants to a tested intervention. The registered 216 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (85% lower).
The record links to 0 conditions, and to 3 interventions - of which Standard Learning is the first listed.
NCT03203954 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03203954 about?
NCT03203954 is a clinical study titled "Testing the Neuroscience of Guided Learning in Depression". Major depression is a prevalent and impairing illness. To better understand the basic science and treatment of depression, the investigators study the behavioral and brain processes associated with learning in depression and how potential disruptions in learning may be repaired. Understanding differ...
What is the current status of trial NCT03203954?
This trial is currently completed. It is a NA study. The enrollment target is 216 participants. The study started on 2016-05-01. Estimated completion is 2021-12.
What interventions are being tested in trial NCT03203954?
The interventions under investigation include: Standard Learning (BEHAVIORAL), Guided Learning: Instructed statistics (BEHAVIORAL), Guided Learning: Changing statistics (BEHAVIORAL).
Who is sponsoring clinical trial NCT03203954?
This trial is sponsored by Virginia Polytechnic Institute and State University, which has 104 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03203954's enrollment target sits among peer trials
216 485th of 2000 higher than 1,514 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02609685 · 216 participants · NA
Active Surveillance of Papillary Thyroid Microcarcinoma
- NCT04994873 · 216 participants · NA
Skills to Enhance Positivity in Suicidal Youth
- NCT05264779 · 216 participants · NA
The Periviable GOALS Decision Support Tool
- NCT05434130 · 216 participants · Phase 2
Modulating Exercise Dosage to Improve Concussion Recovery
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI